The DISC locus in psychiatric illness

JE Chubb, NJ Bradshaw, DC Soares, DJ Porteous… - Molecular …, 2008 - nature.com
The DISC locus is located at the breakpoint of a balanced t (1; 11) chromosomal
translocation in a large and unique Scottish family. This translocation segregates in a highly …

Phosphodiesterases as therapeutic targets for Alzheimer's disease

A García-Osta, M Cuadrado-Tejedor… - ACS chemical …, 2012 - ACS Publications
Alzheimer's disease (AD) is the most common form of dementia among the elderly. In AD
patients, memory loss is accompanied by the formation of beta-amyloid plaques and the …

Novel object recognition test for the investigation of learning and memory in mice

LM Lueptow - Journal of visualized experiments: JoVE, 2017 - pmc.ncbi.nlm.nih.gov
The object recognition test (ORT) is a commonly used behavioral assay for the investigation
of various aspects of learning and memory in mice. The ORT is fairly simple and can be …

Nitric oxide/cGMP/CREB pathway and amyloid-beta crosstalk: from physiology to Alzheimer's disease

MR Tropea, W Gulisano, V Vacanti, O Arancio… - Free Radical Biology …, 2022 - Elsevier
The nitric oxide (NO)/cGMP pathway has been extensively studied for its pivotal role in
synaptic plasticity and memory processes, resulting in an increase of cAMP response …

EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 …

J Prickaerts, NP van Goethem, R Chesworth… - …, 2012 - Elsevier
EVP-6124,(R)-7-chloro-N-quinuclidin-3-yl) benzo [b] thiophene-2-carboxamide, is a novel
partial agonist of α7 neuronal nicotinic acetylcholine receptors (nAChRs) that was evaluated …

Object recognition testing: methodological considerations on exploration and discrimination measures

S Akkerman, A Blokland, O Reneerkens… - Behavioural brain …, 2012 - Elsevier
The object recognition task (ORT) is a popular one-trial learning test for animals. In the
current study, we investigated several methodological issues concerning the task. Data was …

Selective phosphodiesterase inhibitors: a promising target for cognition enhancement

OAH Reneerkens, K Rutten, HWM Steinbusch… - …, 2009 - Springer
Rationale One of the major complaints most people face during aging is an impairment in
cognitive functioning. This has a negative impact on the quality of daily life and is even more …

Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine—a PDE1 inhibitor

R Deshmukh, V Sharma, S Mehan, N Sharma… - European journal of …, 2009 - Elsevier
Enhancing cyclic nucleotides signaling by inhibition of phosphodiesterases (PDEs) is known
to be beneficial in disorders associated with cognitive decline. The present study was …

Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer's disease: a translational overview

PRA Heckman, C Wouters… - Current pharmaceutical …, 2015 - ingentaconnect.com
Phosphodiesterase inhibitors (PDE-Is) enhance cAMP and/or cGMP signaling via reducing
the degradation of these cyclic nucleotides. Since both cAMP and cGMP signaling are …

Tadalafil crosses the blood–brain barrier and reverses cognitive dysfunction in a mouse model of AD

C García-Barroso, A Ricobaraza, M Pascual-Lucas… - …, 2013 - Elsevier
Previous studies have demonstrated that cognitive function can be restored in mouse
models of Alzheimer's disease (AD) following administration of sildenafil, a specific PDE5 …